Erasca, Inc. (ERAS)
NASDAQ·Healthcare·Biotechnology
$18.72
+4.99%
Mkt Cap $6.55B
Analyst Ratings
Buy
8
Hold
3
Sell
0
Price Target (17 analysts)
$17.50
Range $10.00 – $30.00
Implied Upside
-6.5%
Consensus $17.50 vs current $18.72
NASDAQ·Healthcare·Biotechnology
$18.72
+4.99%
Mkt Cap $6.55B
Buy
8
Hold
3
Sell
0
Price Target (17 analysts)
$17.50
Range $10.00 – $30.00
-6.5%
Consensus $17.50 vs current $18.72